Skip to content
LAWYER PROFILE

Covington & Burling LLP

Sarah Cowlishaw

London, UK UK Guide 2022 Ranked in 1 departments
Ranked in : Life Sciences: Regulatory
chambers review
Lawyer Information
chambers review
Lawyer Information

Lawyer profile for UK 2022

UK

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

UK
Life Sciences: Regulatory - UK-wide

Up and Coming

Sarah Cowlishaw has a growing profile in the sector, for her advisory work pertaining to clinical trials and the negotiation of supply agreements.
"Sarah Cowlishaw is talented and a good lawyer, a specialist in commercial clinical trials."
Learn more about this team View ranking table

Lawyer information

This content is provided by Sarah Cowlishaw

Practice Areas

Sarah Cowlishaw supports innovative pharmaceutical, biotech, medical device, diagnostic and software technology companies on regulatory, compliance, transactional, and legislative matters. She is a co-chair of Covington’s multidisciplinary Digital Health Initiative, and regularly advises on legal issues presented by digital health technologies including artificial intelligence.

Sarah has played a pivotal role in negotiating supply arrangements for COVID-19 vaccines and non-vaccine COVID-19 related products, including before the European Commission and the UK Government.

She regularly advises the pharma and device industry on regulatory matters, including on borderline determinations, adverse event and other reporting obligations, manufacturing controls, and labeling and promotion. Sarah is also well equipped to advise clients on the new EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation, and the new UK-specific regulatory regime for medical devices, introduced in January 2021.

On the commercial side, her experience covers the full range of agreements that span the product life-cycle in the life sciences sector. Notably she advised Illumina on its partnership with Genomics England, to sequence up to 500,000 whole genomes for the NHS Genomic Medicine Service. She also advised Sensyne Health on regulatory matters in connection with its £60 million IPO on London’s AIM market.

UK
Sarah Cowlishaw

Covington & Burling LLP

firm
Office

22 Bishopsgate

London

Greater London

UK

EC2N 4 NQ

guide
Ranked In

UK 2022

View Firm Profile
Share profile:

Discover other lawyers at Covington & Burling LLP

View firm profile
Jeremy Wilson
Band 4
Jeremy WilsonCovington & Burling LLPInternational Arbitration London, UK
Jeremy Wilson
Band 4
Jeremy WilsonCovington & Burling LLPInternational Arbitration London, UK
James Gubbins
Band 2
James GubbinsCovington & Burling LLPPrivate Equity: Venture Capital Investment London, UK
James Gubbins
Band 2
James GubbinsCovington & Burling LLPPrivate Equity: Venture Capital Investment London, UK
Daniel Pavin
Band 2
Daniel PavinCovington & Burling LLPLife Sciences: Transactional London, UK
Daniel Pavin
Band 2
Daniel PavinCovington & Burling LLPLife Sciences: Transactional London, UK
Craig Pollack
Band 3
Craig PollackCovington & Burling LLPCommercial and Corporate Litigation London, UK
Craig Pollack
Band 3
Craig PollackCovington & Burling LLPCommercial and Corporate Litigation London, UK